Concepedia

Mark D. Tricklebank

MD

Statistics

Publications

98

Citations

6.7K

H-Index

48

Active since

1976

Affiliations

Eli Lilly (United Kingdom)(Current)

Eli Lilly (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

MSD (UK) Limited (United Kingdom)

King's College London

Mark D. Tricklebank is an author at Eli Lilly (United Kingdom) specializing in neuropharmacology, neuroscience, and medicine.

ORCID

Publications per year

1976–2023

98

Publications

98

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-Propylamino) tetralin in the rat

Mark D. Tricklebank, Christian Forler, John R. Fozard · European Journal of Pharmacology · 1984 · 677 citations

, , +16

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

Mark D. Tricklebank, Lakhbir Singh, Ryszard J. Oles et al. · European Journal of Pharmacology · 1989 · 437 citations

, , +12

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity

Gerard R. Dawson, Susan P. Crawford, Neil Collinson et al. · Psychopharmacology · 1995 · 175 citations

, , +12

The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor

Mark D. Tricklebank · Trends in Pharmacological Sciences · 1985 · 168 citations

, , +14

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

François Gilbert, C. Brazell, Mark D. Tricklebank et al. · European Journal of Pharmacology · 1988 · 167 citations

, , +13

1–5 of 98